The in vitro effect of imipenem and ofloxacin on enzymic activity of Klebsiella strains

Folia Microbiologica

Volumn 45, Issue 5, 2000, Pages 387-390

  Hostacka A ^a  

^a INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; IMIPENEM; OFLOXACIN; THIENAMYCIN DERIVATIVE; TRIACYLGLYCEROL LIPASE; UREASE;

ARTICLE; CLASSIFICATION; DRUG EFFECT; ENTEROBACTER INFECTION; ENZYMOLOGY; HUMAN; KLEBSIELLA; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

ANTI-INFECTIVE AGENTS; HUMANS; IMIPENEM; KLEBSIELLA; KLEBSIELLA INFECTIONS; LIPASE; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; THIENAMYCINS; UREASE;

EID: 0034577211     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02817610     Document Type: Article

References (28)

1. ARLET G.M., ROUVEAU M., CAVIN I., BOUVET P.J.M., LAGRANGE P.H., PHILIPPON A.: Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4-β-lactamase and which were isolated in 14 French hospitals. J.Clin.Microbiol. 32, 2553-2558 (1994).
2. COPPI G., BONARDI G.: Urease-inhibiting activity of some drugs in vitro and in vivo. Arzneim.Forsch. 20, 384-387 (1970).
3. COWAN S.T. (Ed.): Cowan and Steel's Manual for the Identification of Medical Bacteria, 2nd ed., pp. 137-180. Cambridge University Press, Cambridge 1974.
4. GRIF K., DIERICH M.P., KARCH H., ALLERBERGER F.: Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents. Eur.J.Clin.Microbiol.Infect.Dis. 17, 761-766 (1998).
5. GRIMOOD K., To M., RABIN H.R., WOODS D.E.: Inhibition of Pseudomonas aeruginosa exoenzyme expression by subinhibitory antibiotic concentrations. Antimicrob.Agents Chemother. 33, 41-47 (1989).
6. HAMILTON-MILLER J.M.T., GARGAN RA.: Rapid screening for urease inhibitors. Invest.Urol. 16, 327-329 (1979).
7. HANBERGER H., GARCIA-RODRIGUEZ J.A., GOBERNADO M., GOOSSENS H., NILSSON L.E., STRUELENS M.J. and the French and Portuguese ICU Study Groups: Antibiotic susceptibility among aerobic Gram-negative bacilli in intensive care units in 5 European countries. J.Am.Med.Assoc. 281, 67-71 (1999).
8. HOŠTACKÁ A., MAJTÁN V.: Alterations in Pseudomonas aeruginosa exoproducts by sub-MICs of some antibiotics. Folia Microbiol. 38, 349-352 (1993).
9. HOŠTACKÁ A.: Vascular permeability factor and lipase produced by Acinetobacter baumannii treated with imipenem. Biomed. Lett. 60, 91-96 (1999).
10. KOLÁŘ M., HÁJEK V., KANTOR L., WIEDERMANN J., KOUKALOVÁ D.: Prevalence of strains of Klebsiella pneumoniae resistant to cephalosporins of the third generation at the pædiatric clinic of the faculty hospital in Olomouc. Epidemiol.Mikrobiol.Imunol. 44, 111-114 (1995).
11. LEGAKIS N.J., TZOUVELEKIS L.S., TSAKRIS A., LEGAKIS N.J., VATOPOULOS A.C.: On the incidence of antibiotic resistance among gram-negative rods isolated in Greek hospitals. J.Hosp.Infect. 24, 233-237 (1993).
12. LONON M.K., WOODS D.E., STRAUS D.: Production of lipase by clinical isolates of Pseudomonas cepacia. J.Clin.Microbiol. 26, 979-984 (1988).
13. MOLINARY G., GUZMÁN C.A., PESCE A., SCHITO G.C.: Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics. J.Antimicrob.Chemother. 31, 681-688 (1993).
14. PODSCHUN R., ULLMANN U.: Incidence of Klebsiella planticola among clinical Klebsiella isolates. Med.Microbiol.Lett. 3, 90-95 (1994).
15. PODSCHUN R., ULLMANN U.: Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin.Microbiol.Rev. 11, 589-603 (1998).
16. ROLLOF J., BRACONIER J.H., SÖDERSTRÖM C., NILSSON-EHLE P.: Interference of Staphylococcus aureus lipase with human granulocyte function. Eur.J.Clin.Microbiol.Infect.Dis. 7, 505-510 (1988).
17. SCHMITZ F.J., VERHŒF J., HADDING U., HEINZ H.P., JONES M.E.: Reduction in cytokine release from human monocytes by modifications in cell wall structure of Staphylococcus aureus induced by subinhibitory concentrations of oxacillin. J.Med.Microbiol. 47, 533-541 (1998).
18. SMITH J.M.B., CHAMBERS S.T.: Klebsiella oxytoca revealing decreased susceptibility to extended spectrum β-lactamases. J.Antimicrob.Chemother. 36, 265-267 (1995).
19. SOFER D., GILBOA-GARBER N., BELZ A., GARBER N.C.H.: Subinhibitory erythromycin represses production of Pseudomonas aeruginosa lectins, autoinducer and virulence factors. Chemotherapy 45, 335-341 (1999).
20. STAMM W.E., MCKEVITT M., ROBERTS P.L., WHITE N.J.: Natural history of recurrent urinary tract infections in women. Rev. Infect.Dis. 13, 77-84 (1991).
21. STRAUS D.C., LONON M.K., HUTSON J.C.: Inhibition of rat alveolar macrophage phagocytic function by a Pseudomonas cepacia lipase. J.Med.Microbiol. 37, 335-340 (1992).
22. TAKEUCHI H., KOBASHI K., YOSHIDA O.: Prevention of infected urinary stones in rats by urease inhibitors. Invest.Urol. 18, 102-105 (1980).
23. TATEDA K., ISHII Y., HIRAKATA Y., MATSUMOTO T., OHNO A., YAMAGUCHI K.: Profiles of outer membrane proteins and lipopolysaccharide of Pseudomonas aeruginosa grown in the presence of sub-MICs of macrolide antibiotics and their relation to enhanced serum sensitivity. J.Antimicrob.Chemother. 34, 931-942 (1994).
24. TIRUNARAYANAN M.O., LUNDBECK H.: Investigations on the enzymes and toxins of staphylococci. Acta Pathol.Microbiol.Scand. 72, 263-276 (1968).
25. WARREN J.W., TENNEY J.H., HOOPES J.M., MUNCIE H.L., ANTHONY W.C.: A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J.Infect.Dis. 146, 719-723 (1982).
26. WILLIAMS P., TOMÁS J.M.: The pathogenicity of Klebsiella pneumoniae. Rev.Med.Microbiol. 1, 196-204 (1990).
27. YINNON A.M., BUTNARU A., RAVEH D., JERASSY Z., RUDENSKY B.: Klebsiella bacteremia: community versus nosocomial infection. Month.J.Assoc.Physic. 89, 933-941 (1996).
28. YOH M., FRIMPONG E.K., VORAVUTHIKUNCHAI S.P., HONDA T.: Effect of subinhibitory concentrations of antimicrobial agents (quinolones and macrolides) on the production of verotoxin by enterohemorrhagic Escherichia coli O157:H7. Can.J. Microbiol. 45, 732-739 (1999).